GSA Capital Partners »

Caris Life Sciences shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $411k 15k 26.98

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Caris Life Sciences

J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
PointState Capital
Millennium Management
Neuberger Berman Group
OrbiMed Advisors
BlackRock
UBS Group
Point72 Asset Management
Ameriprise Financial
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences